Assessing facial features in Marfan syndrome
Official title: Marfan Syndrome (MFS) and Facial Dysmorphism: Non-invasive 3D Assessment
Run by IRCCS Policlinico S. Donato · NCT05702476 · Data updated 2026-11-12
This study is trying to identify and track the facial features of people with Marfan syndrome to help with earlier diagnosis and understanding of the condition.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | IRCCS Policlinico S. Donato Academic / other |
| Locations | 1 site (San Donato Milanese, Lombardy) |
| Status | Recruiting |
| Started | January 9, 2023 |
| Main results expected | June 2026 |
| Study ends | June 2027 |
| Registry record updated | January 13, 2025 |
| Trial ID | NCT05702476 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals of white European ethnicity diagnosed with Marfan syndrome.
✕Probably not a fit
Patients with previous craniofacial trauma or surgery, those with facial hair, or pregnant individuals may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to define the facial morphological features associated with Marfan syndrome (MFS) and track their evolution over time. It will investigate the relationship between these facial characteristics and the diagnostic criteria for MFS. By focusing on the craniofacial features, the study seeks to enhance early diagnosis and understanding of the syndrome's manifestations. The research will involve participants of white European ethnicity who provide informed consent.
Why it matters
Potential benefit: If successful, this study could improve early diagnosis and management of Marfan syndrome through better understanding of its facial features.
How similar studies have gone: While few studies have explored facial features in Marfan syndrome, this approach is relatively novel and aims to fill a significant gap in the literature.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * White european ethnicity; * Signed informed consent; Exclusion Criteria: * Previous relevant traumas affecting the craniofacial district or maxillofacial surgery; * Presence of beard and mustache; * Pregnancy
Where it's running
-
IRCCS Policlinico San Donato
San Donato Milanese, Lombardy, Italy Recruiting
Study contacts
- Principal investigator: Alessandro Pini, MD — Cardiovascular-Gentic Centre, IRCCS Policlinico San Donato
- Study coordinator: Alessandro Pini, MD
- Email: alessandro.pini@grupposandonato.it
- Phone: +390252774705
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Psychological support for adults with Marfan syndrome
This study looks at why adults with Marfan syndrome seek psychological support and how their condition affects their mental health and coping skills.
-
Pregnancy-Related Aortic Dissection in China
This study looks at cases of aortic dissection that occur during pregnancy or shortly after, to understand outcomes for mothers and babies.
-
AI-assisted Rare-Disease Diagnosis
A multicenter randomized test to see if an AI diagnostic tool can help doctors make faster, more accurate rare-disease diagnoses for patients with unresolved symptoms.
-
Socio‑professional inclusion for young people (15–25) with childhood-onset rare genetic disabilities
This project will try to see what makes it hard for 15–25‑year‑olds with childhood-onset rare genetic conditions to access higher education, internships, or work.
-
Treatment approaches for AChR-antibody positive generalized myasthenia gravis in Russia.
This project will look at which treatments adults in Russia with AChR-antibody positive generalized myasthenia gravis receive and how their symptoms and hospitalizations change over time.
-
Long-term outcomes for people with immune TTP in the French national TMA cohort
This project uses past medical records to see long-term health outcomes and complications in people in France who had immune thrombotic thrombocytopenic purpura (iTTP).
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.